Potential [qlco]    
base [ftcn]    
Therapies [topp]    
Non-alcoholic Fatty Liver Disease [dsyn]    
Epidemic [phpr]    
Parallel [qlco]    
Increase [qnco]    
Prevalence [qnco]    
Obese [dsyn]    
Diabetes [dsyn]    
Risk factor [qnco]    
Review [inpr]    
Present [qnco]    
Current [tmco]    
Pre-clinical [qlco]    
Evidence [ftcn]    
Show [inpr]    
GLP-1 Analogue [chvf]    
DPP4 [gngm]    
Inhibitor [chvf]    
hepatic steatosis [dsyn]    
Effect [qlco]    
Overall [inpr]    
Improved [cnce]    
Metabolic [ftcn]    
Parameter [fndg]    
Data [idcn]    
Support [medd]    
Improved [cnce]    
Weight Loss [fndg]    
Direct [qlco]    
Effect [qlco]    
Hepatocyte [cell]    
In Vitro [inpr]    
Multiple [qnco]    
Hepatocyte [cell]    
Signal Transduction Pathway [moft]    
APPEAR [qlco]    
To [qlco]    
Activate [acty]    
GLP-1 [aapp]    
Analogue [chvs]    
proposal [idcn]    
To [qlco]    
Improved [qlco]    
hepatic steatosis [dsyn]    
controversies [socb]    
Pancreatic [bpoc]    
Type [qlco]    
Present [qnco]    
Response [fndg]    
GLP-1 [aapp]    
Signal [phpr]    
Hepatocyte [cell]    
% total [qnco]    
Data [idcn]    
Support [medd]    
Need [qlco]    
More [ftcn]    
Rigor [sosy]    
prospective [resa]    
Clinical Trial [resa]    
Further [spco]    
investigate [ftcn]    
Potential [qlco]    
Therapies [topp]    
treatment [ftcn]    
Non-alcoholic Fatty Liver Disease [dsyn]    
[c] [qnco]    
Rights [qlco]    
Reservation [acty]    
